HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate “Superior” Anti-Cavity Toothpaste Launching In Emerging Markets

This article was originally published in The Tan Sheet

Executive Summary

Colgate-Palmolive CEO Ian Cook highlights innovations targeted to emerging markets, including a new toothpaste containing acid-neutralizing technology for advanced cavity prevention.

You may also be interested in...



Colgate Builds Domestic Oral Care With Freshening, Sensitivity Pastes

Colgate-Palmolive will introduce Colgate Max Fresh Cool Scrub and Colgate Sensitive SmartFoam with Whitening in the third quarter, firm announces July 24. Launches will build on momentum generated by oral-care entries in the second quarter, when North American sales climbed 5%.

Colgate Leans On Retail Marketing, New Products For Market Edge

Colgate-Palmolive hopes to expand its oral care position with online and in-store marketing, educational outreach and a "very rich pipeline of new products," a top executive said

China Regulatory Probe Slows Nu Skin Growth After Record Year

The firm’s recent explosive growth is expected to slow substantially in the first quarter – to between 20% and 24% – but Nu Skin is confident the steps it is taking in China “make our long-term success more likely.” Analysts have faith in the firm as it works with Chinese officials to resolve an investigation into its business practices.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124362

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel